Market Research Reports- Consulting Analysis Crystal Market Research Pen Needle Market by Type, Needle Length, Therapy | Page 2

Browse full research report with TOC on “Pen Needle Market by Type, Needle Length,
Therapy and Mode of Purchase - Global Industry Analysis and Forecast to 2025” at:
http://www.crystalmarketresearch.com/report/pen-needle-market
Standard pen needles segment dominated the global market in 2016, due to growing awareness
among consumers about the availability of safe insulin delivery methods, increasing prevalence
of diabetes with rise in geriatric population, and standard pen needles being cost effective as
compared to other insulin delivery methods. However, standard pen needles are expected to
witness decline in the growth during forecast period due to various risks of needle related
injuries such as rupture of blood vessel while injecting insulin in the body. Among various
needles available, 8mm needle length accounted for the largest share of the global market in
2016; as these needles are prescribe to large number of people including obese people. Insulin
therapy segment dominated the overall market in 2016, primarily due to increasing adoption of
self-administration of insulin for diabetes type-1 as well as type-2. With increasing trend in e-
commerce, online purchase segment will witness high growth during the forecast period.
Europe accounted for the major share of the global pen needles market in 2016, primarily due to
rising diabetic population, increased funding for diabetic research, high adoption of
technologically advanced devices, and rise in demand for safe insulin delivery methods.
However, Asia-Pacific is expected to witness high growth in forecast period, due to increasing
demand for better healthcare infrastructure and rise in awareness about commercially available
treatments for diabetes.
Request a sample copy of Pen Needle Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0515
Major players in the market are Becton, Dickinson and Company, Novo Nordisk A/S, Owen
Mumford, Ltd., HTL-STREFA S.A., B. Braun Melsungen, Ypsomed Holding AG, Terumo
Corporation, and Allison Medical, Inc. These players are highly focused on developing advanced
products for the treatment of diabetes. For instance, in 2013, Becton, Dickinson and Company
launched BD Ultra-Fine Nano 4mm pen needle with easy flow technology for easier and faster
delivery of insulin in the body. Advanced features such as easy flow with 5mm needles and
digitalized pen needles will dominate the market in coming years.
Key Findings of the Research Study: